Medication Adherence and its Predictors in Patients With Type 2 Diabetes Mellitus in India: A Systematic Review and
Saurav Basu1, Trina Sengupta1, Satyajit Kundu2,3
1Department of Community Medicine ESI PGIMSR & ESIC Medical College and Hospital Kolkata India.
Background And Aims:
India has nearly 90 million (10.5%) patients living with type 2 diabetes mellitus (T2DM) with a high burden of suboptimal medication adherence. This systematic review and meta-analysis aimed to synthesize the determinants of medication adherence in Indian patients with T2DM, estimate the pooled prevalence of adherence, and formulate evidence-based recommendations for public health policy.
Methods:
We conducted a systematic review and meta-analysis of observational and experimental studies from India, published between January 2020 and December 2024. Electronic databases (PubMed, Scopus, Web of Science) were searched for studies reporting the proportion of patients reporting poor adherence to anti-diabetic medications.
Results:
A total of 534 articles were identified after removing duplicates and assessed for eligibility, of which 16 studies were included in this SRMA. The pooled prevalence of medication non-adherence among MMAS-8 using studies (n = 4) was 48% (95% CI: 18%-79%), and, overall, among all the studies ranged from 11% to 68%. Predictors of poor adherence included older age, socio-economic disadvantage, substance use, treatment complexity, psychological distress, polypharmacy, and health-system access barriers. Information on comorbidity and multimorbidity was sparse. Furthermore, a key limitation was that studies using the Morisky adherence scales (MMAS-4/8) did not report individual item responses, which precluded a granular analysis of specific reasons for non-adherence. There were eight studies from South India and six from north and north-eastern India, indicating a significant lack of geographic diversity.
Conclusion:
Medication non-adherence in patients with T2DM persists as a major public health challenge in India, further exacerbating the country's burgeoning diabetes epidemic. Strengthening primary care can address the primary factors contributing to significant non-adherence in this population.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Drug Therapy
Antianxiety Medications
